Can stem cell therapy reduce lung rejection?
Lung Disease

Can stem cell therapy reduce lung rejection?

50% of lung transplant patients will experience rejection within five years of transplant and the prospect of a second transplant; scary odds for someone who’s just gone through the major life change and trauma of transplant surgery. At The Prince Charles Hospital Dr Dan Chambers is exploring the use of stem cells to increase the life-expectancy of these patients.

Dr Chambers is leading a nationwide study using stem cell therapy to treat lung transplant rejection and improve acceptance rates and transplant lung function in patients – vastly improving their odds and quality of life.

This study is the largest lung stem cell therapy study in the world, and could completely revolutionise treatments for all sorts of diseases. It even has the potential to translate to other organ failure such as liver or kidney.

Clinical trials are underway with the collection of specific cells, which have been identified as being “reprogrammed” during treatment with mesenchymal stromal cells (MSCs), from patients with lung rejection before and after MSC treatment. These cells will form the base of further testing to identify the effectiveness of stem cell therapy – does it work, and if it does how is it working? Understanding the answers to these questions could be the beginning of a revolutionary treatment for lung rejection.

Together with the Prince Charles Hospital Foundation and the University of Queensland, Dr Chambers’ hope is to establish a dedicated lung stem cell therapy centre at The Prince Charles Hospital.

Support The Common Good here

Published: June 11, 2019

Related news & events

What is a Giving Day?

The Common Good

What is a Giving Day?

What is a Giving Day? Giving days are becoming an increasingly popular way to fundraise. We explain what they are and the benefits.

Find out more

Grandfriends Ageless Play Program in Brisbane Expands

Aging

Grandfriends Ageless Play Program in Brisbane Expands

Grandfriends ageless play program in Brisbane expands thanks to support generated at The Common Good's 2022 Giving Day.

Find out more

Dementia Action Week 2023: ‘Act Now for a Dementia-Friendly Future’

Aging

Dementia Action Week 2023: ‘Act Now for a Dementia-Friendly Future’

Dementia Action Week 2023 runs from the 18th to the 24th of September: Dementia Australia is encouraging people to ‘act now for a dementia-friendly future’.

Find out more

Healing Ceilings Installed at Brisbane’s The Prince Charles Hospital

Hospital Care

Healing Ceilings Installed at Brisbane’s The Prince Charles Hospital

Some of the sickest patients in The Prince Charles Hospital’s thoracic ward can now look up and let their minds wander into nature, following the installation of Healing Ceilings.

Find out more

Include a Charity Week 2023: The Impact of Leaving a Gift in Will

The Common Good

Include a Charity Week 2023: The Impact of Leaving a Gift in Will

Have you heard of Include a Charity Week? Click here to read about the social change campaign and how you can have a lasting impact.

Find out more

What is Lung Disease?

Lung Disease

What is Lung Disease?

In this blog, we explain what lung disease is, discuss different types of lung disease and shed some light on common misconceptions.

Find out more

Ekka Strawberry Sundae Sales Records Tumble in 2023

The Common Good

Ekka Strawberry Sundae Sales Records Tumble in 2023

Ekka Strawberry Sundae Sales 2023: Sunny skies, soaring temps and support from showgoers all combined to create record-breaking sales.

Find out more

Idiopathic Pulmonary Fibrosis (IPF): What is it?

Lung Disease

Idiopathic Pulmonary Fibrosis (IPF): What is it?

Idiopathic Pulmonary Fibrosis is “a disease that afflicts many people at random.” Learn more about it in this blog.

Find out more

Bill Van Nierop: Life After Transplant

Lung Disease

Bill Van Nierop: Life After Transplant

Bill Van Nierop is incredibly grateful for the life-saving transplant he received. In this blog, we share more about Bill’s life and challenges he’s experienced after transplant.

Find out more